Log in to save to my catalogue

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host diseas...

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host diseas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fb5dbe4f7ca47b3843e653ce28866c4

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

About this item

Full title

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

Publisher

England: BioMed Central Ltd

Journal title

Journal of hematology and oncology, 2016-10, Vol.9 (1), p.113-113, Article 113

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Graft-versus-host disease (GvHD) remains the major obstacle to successful allogeneic hematopoietic stem cell transplantation, despite of the immunosuppressive regimens administered to control T cell alloreactivity. PI3K/AKT/mTOR pathway is crucial in T cell activation and function and, therefore, represents an attractive therapeutic target to preve...

Alternative Titles

Full title

Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5fb5dbe4f7ca47b3843e653ce28866c4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fb5dbe4f7ca47b3843e653ce28866c4

Other Identifiers

ISSN

1756-8722

E-ISSN

1756-8722

DOI

10.1186/s13045-016-0343-5

How to access this item